Astal Laboratories Board Meeting on Nov 13 to Approve Q2 FY27 Results

Astal Laboratories Ltd has announced a Board of Directors meeting scheduled for November 13, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, along with the auditors' limited review report. Additionally, the meeting will address any other business with the chair's permission. In compliance with SEBI regulations, the trading window for designated persons will be closed from October 1, 2026, until 48 hours after the board meeting concludes.